期刊文献+

干扰素对肿瘤细胞Fas表达的上调作用及与细胞凋亡的关系 被引量:2

Interferon-γ up-regulates Fas expression and increases Fas-mediated apoptosis in tumor cell lines
下载PDF
导出
摘要 目的研究干扰素(IFN)对肿瘤细胞表面Fas表达的调控,探讨其致凋亡机制。方法通过流式细胞仪测定肿瘤细胞的Fas表达,应用ELISA及Annexin V 染色检测细胞凋亡。对干扰素及抗Fas单克隆抗体诱导的肿瘤细胞凋亡进行评价。结果胃癌细胞系Kato-Ⅲ、AGS、肺癌细胞A549及喉癌细胞Hep-2均有不同程度的Fas表达,上述细胞与IFN-酌作用后Fas表达升高(P<0.05);IFN- 酌单独即可引起肿瘤细胞凋亡,同时可增加肿瘤细胞对抗Fas抗体的敏感性;IFN- 酌致凋亡及调节Fas表达的作用有时间依赖性,但不同细胞系对这两种因素致凋亡的敏感性不同。结论IFN治疗肿瘤的作用机制之一是增加肿瘤细胞Fas表达而致其凋亡,表明该药在肿瘤生物治疗中应用的合理性。 Objective To investigate effect of interferon-γ (IFN-γ) on Fas expression and Fas-mediated apoptosis in tumor cell lines. Methods Fas expression was detected by flow cytometry, and the tumor cell apoptosis evaluated by enzyme-linked immunosorbent assay and AnnexinV staining assay. Results All the 4 tumor cell lines used in this study, e.g. gastric cancer cell lines Kato-Ⅲand AGS, lung cancer cell line A549 and laryngeal cancer cell line Hep-2, expressed Fas protein to varied degrees. Fas expression was up-regulated by IFN-γ (P<0.05), which alone was enough to induce apoptosis in tumor cells and increase the susceptibility of them to anti-Fas antibodies. IFN-γ induced Fas expression up-regulation and tumor cell apoptosis in a time-dependent manner. Conclusion Fas-mediated apoptosis is one of the mechanisms for IFN-γ to exercise its anti-tumor effect.
出处 《第一军医大学学报》 CSCD 北大核心 2002年第12期1090-1092,共3页 Journal of First Military Medical University
关键词 肿瘤细胞 FAS表达 细胞凋亡 干扰素γ CD95抗原 脱噬作用 基因表达调控 流式细胞术 酶联免疫吸附测定 interferon-gamma, recombinant antigens, CD95 apoptosis gene expression regulation, neoplastic flow cytometry enzyme-linked immunosorbent assay
  • 相关文献

参考文献9

  • 1Martin SJ, Green DR. Apoptosis as a goal of cancer therapy[J]. Curr Opin Oncol, 1994, 6(6): 616-21.
  • 2Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member ofthe nerve growth factor/ umor necrosis factor receptor superfamily, in normal and neoplastic cells[J]. Lab Invest, 1993, 69(4): 415-29.
  • 3Basolo F, Fiore L, Baldanzi A, et al. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thy roid carcinoma[J]. Lab Invest, 2000, 80(9): 1413-9.
  • 4Frankfurt OS. Detection of apoptosis in leukemic and breast cancer c ells with monoclonal antibody to single-stranded DNA[ J ]. Anticancer Res, 1994, 14 (SA): 1861-9.
  • 5Sandstrom K, Hakansson L, Lukinius A, et al . A method to studyapoptosis in eosinophils by flow cytometty[J]. J Immtmol Methods, 2000, 240(1-2): 55-68.
  • 6谭黎杰,仇德惠.Fas/FasL与肿瘤局部及全身性免疫抑制[J].中国癌症杂志,2000,10(4):363-366. 被引量:4
  • 7Cefai D, Favre L, WattendorfE, et al. Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model[J]. Int J Cancer, 2001, 91(4): 529-37.
  • 8聂志林,靳风烁,李黔生,江军,王洛夫.Fas配体在膀胱肿瘤细胞系免疫逃逸中的作用[J].中华泌尿外科杂志,2000,21(8):456-458. 被引量:4
  • 9O'Connell J, O'Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas lig and[J]. J Exp Med, 1996, 184(3): 1075-82.

二级参考文献36

  • 1Lee R K,J Immunol,1996年,157卷,1919页
  • 2俞莉章,中华泌尿外科杂志,1989年,10卷,131页
  • 3TheresaL,WhitesideTL,RabinowichH.TheroleofFas/FasLinimmunosupressioninducedbyhumantumors[J].CancerImmunolImmunother,1998,46(4):175-184.
  • 4MizutaniY,OkadaY,YoshidaO,etal.DoxorubicinsensitizeshumanbladdercarcinomacellstoFas-mediatedcytotoxicity[J].Cancer,1997,79(6):1180-1189.
  • 5RothW,FontanaA,TrepelM,etal.Immunochemotherapyofmalinantglioma:synergisticactivityofCD95ligandandchemotheraprutics.[J].CancerImmunolimmunother,1997,44(1):53-63.
  • 6HahneM,RimoldiD,SchroterM,etal.MelanomacellexpressionofFas(Apo1/CD95)ligand:implicationsoftumorimmuneescape[J].Science,1996,274(5291):1363-1366.
  • 7O'ConnellJ,O'SullivanGC,CollinsJE,etal.TheFascounterattack:Fas-mediatedTcellkillingbycoloncancercellsexpressingFasligand[J].JExpMed,1996,184(3):1075-1082.
  • 8RbinowichH,SuminamiY,ReichertTE,etal.Expressionofcytokinegenesorproteinsandsignalingmoleculesinlymphocytesassociatedwithhumanovariancarcinoma[J].IntJCancer,1996,68(3):276-284.
  • 9GratacC.Up-regulationofFas(APO-1/CD95)ligandanddown-regulationofFasexpressioninhumanesophagealcancer[J].CancerRes,1998,58(10):2057-2062.
  • 10NiehansGA,BrunnerT,FrizelleSP,etal.HumanlungcarcinomaexpressFasLlignad[J].CancerRes,1997,57(6):1007-1012.

共引文献6

同被引文献32

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部